About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

VVC Sampling Study for Analysis Validation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05327192

VVC Sampling Study for Analysis Validation

This is a biomarker multi-centre study to validate an extraction method of fungal and bacterial DNA extracted from vaginal swabs from adult women with confirmed VVC. The study population will consist...

Lead sponsor: Gedea Biotech AB•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Gedea Biotech AB

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Adult women aged 18 years or older
•2. Diagnosis of VVC, defined as having a white or creamy vaginal discharge plus the following findings:
•1. At least 2 of the following signs and symptoms of VVC that are characterized as at least moderate: itching, burning, irritation, edema, redness, or excoriation.
•2. Potassium hydroxide (KOH) or saline preparation from the inflamed vaginal mucosa or secretions revealing yeast forms (hyphae or pseudohyphae) or budding yeasts.
•3. Having decisional capacity and providing written informed consent
•4. Signed informed consent and willing and able to comply with all study requirements

Exclusion Criteria

•None

Related studies

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

NCT06983041 · Vulvovaginal Candidiasis (VVC), Yeast Vaginitis

RECRUITINGPhase 2/3

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

NCT06835361 · Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC)

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

NCT05908682 · Vulvovaginal Candidiasis, Candida Infection, and more

DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy

NCT06397248 · Vulvovaginal Candidiasis

Comparative Performance of a Vaginal Yeast Test

NCT05079711 · Vulvovaginal Candidiasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 18, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment10

Start dateMay 2022

Last updatedAug 18, 2022

Condition

Vulvovaginal Candidiasis

Locations shown

Nottingham University Hospitals NHS Trust

Nottingham

Research and Development Department, Berkshire Healthcare NHS Foundation Trust

Slough

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions